Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial

D Lorusso, G Ferrandina, N Colombo, S Pignata, A Pietragalla, C Sonetto, C Pisano, M T Lapresa, A Savarese, P Tagliaferri, D Lombardi, S Cinieri, E Breda, I Sabatucci, R Sabbatini, C Conte, S C Cecere, G Maltese, G Scambia

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial'. Together they form a unique fingerprint.

Medicine & Life Sciences